Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Fatty Liver Disease NAFLD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07580482
What this trial is testing

The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral

Who this might be right for
Liver DiseasesLiver FatDiabetes Mellitus, Type 2+1 more
University of Kansas Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00590161
What this trial is testing

Pentoxifylline in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Case Western Reserve University 55
Very early researchStudy completedNCT05552274
What this trial is testing

FTIH of ECC4703 in Healthy Volunteers

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Eccogene 75
Testing effectiveness (Phase 2)Study completedNCT03118310
What this trial is testing

Treatment of NAFLD With Two Different Diets

Who this might be right for
NAFLD
Karolinska University Hospital 74
Not applicableStudy completedNCT05416970
What this trial is testing

The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Campania Luigi Vanvitelli 122
Large-scale testing (Phase 3)Study completedNCT00244569
What this trial is testing

Development of a Breath Test for Monitoring Patients With Liver Disease

Who this might be right for
Fatty LiverCirrhosis
Virginia Commonwealth University 120
Not applicableStudy completedNCT02181270
What this trial is testing

Changes in Intrahepatic Lipids With Exercise

Who this might be right for
Obese
University of Missouri-Columbia 57
Not applicableStudy completedNCT03060694
What this trial is testing

Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 58
Not applicableStudy completedNCT03135873
What this trial is testing

Mastiha Treatment for Obese With NAFLD Diagnosis

Who this might be right for
Non Alcoholic Fatty Liver Disease
Harokopio University 100
Not applicableUnknownNCT04282005
What this trial is testing

Metabolic Surgery for Steato-Hepatitis

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Non-Alcoholic Steato-Hepatitis (NASH)
King's College London 28
Not applicableNot Yet RecruitingNCT06038253
What this trial is testing

Relation Between NAFLD and BM DENSITY

Who this might be right for
NAFLDOsteoporosis
Assiut University 100
Not applicableStudy completedNCT01285362
What this trial is testing

Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Columbia University 8
Not applicableStudy completedNCT07103603
What this trial is testing

MHT and Liver Function in Postmenopausal Women

Who this might be right for
MenopauseNon Alcholic Fatty Liver DiseaseHepatic Steatosis
Ipek B. Ozcivit Erkan, MD 44
Not applicableStudy completedNCT02647294
What this trial is testing

Polyunsaturated Fatty Acids in Patients With NAFLD.

Who this might be right for
NAFLD
General University Hospital, Prague 60
Early research (Phase 1)Study completedNCT04643795
What this trial is testing

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

Who this might be right for
Hepatic ImpairmentNASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 87
Testing effectiveness (Phase 2)Looking for participantsNCT05842512
What this trial is testing

Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Polaris Group 60
Testing effectiveness (Phase 2)Study completedNCT02653300
What this trial is testing

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)Type2 Diabetes Mellitus
Oramed, Ltd. 10
Not applicableStudy completedNCT05480007
What this trial is testing

Non-alcoholic Fatty Liver Disease and Its Treatment

Who this might be right for
NAFLD
Shanghai 10th People's Hospital 68
Not applicableStudy completedNCT02176811
What this trial is testing

Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Gulhane School of Medicine 80
Post-approval studies (Phase 4)WithdrawnNCT02263677
What this trial is testing

Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
University of Missouri-Columbia
Next Page